SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹18,194 Cr | ₹16,984 Cr | ₹19,906 Cr | ₹17,208 Cr | ₹16,146 Cr |
What is the latest Total Current Liabilities ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹18,194 Cr |
| Mar2024 | ₹16,984 Cr |
| Mar2023 | ₹19,906 Cr |
| Mar2022 | ₹17,208 Cr |
| Mar2021 | ₹16,146 Cr |
How is Total Current Liabilities of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18,194 Cr | 7.13 | |
| Mar2024 | ₹16,984 Cr | -14.68 | |
| Mar2023 | ₹19,906 Cr | 15.68 | |
| Mar2022 | ₹17,208 Cr | 6.58 | |
| Mar2021 | ₹16,146 Cr | - | |
Compare Total Current Liabilities of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,984.7 Cr | 0.1% | -3.2% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,371.0 Cr | -1.5% | -7.3% | 2.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,229.0 Cr | -1.3% | -0.7% | 24.4% | Stock Analytics | |
| CIPLA | ₹108,441.0 Cr | 1.5% | -8.1% | -6.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,407.0 Cr | 3.2% | 5.6% | 3.1% | Stock Analytics | |
| MANKIND PHARMA | ₹85,977.0 Cr | -3.4% | -7.7% | -20.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 0.1% |
-3.2% |
-2.6% |
| SENSEX | 2.9% |
-1.1% |
8.5% |
You may also like the below Video Courses